Skip to main content

Day: May 9, 2022

Notice of public offering, listing and admission to trading of units of EfTEN United Property Fund

Written by Customer Service on . Posted in Public Companies.

EfTEN Capital AS (registry code 11505542, address A. Lauteri tn 5, 10114 Tallinn) as the management company of the EfTEN United Property Fund announces a public offering of the units of the EfTEN United Property Fund. Offering of units The Management Company organizes the offering of up to 500,000 fund units to all natural and legal persons in Estonia in accordance with the public offering prospectus of the units. The offer is divided to interim periods. During the first interim period, i.e. from 9.00 am (EET) on 09.05.2022 to 11.00 am on 20.05.2022 (EET), the Management Company will offer and the Fund will issue 460,000 offered units. The Management Company has the right to increase the offer by 300,000 offered units during the first interim period. From the second interim period until the end of the offer period, i.e. from 9.00 am (EET)...

Continue reading

Nykode Therapeutics announces positive interim results from its Phase 2 trial with VB10.16 in combination with immune checkpoint inhibitor atezolizumab in advanced cervical cancer

Written by Customer Service on . Posted in Public Companies.

VB10.16 in combination with atezolizumab demonstrated an ORR of 21%, including 2 CRs and 6 PRs, in a heavily pre-treated population of patients with HPV16-positive advanced cervical cancer VB10.16 in combination with atezolizumab demonstrated a very high DCR of 64% Anti-tumor activity of VB10.16 in combination with atezolizumab was observed both in PD-L1 positive patients (ORR of 27%; DCR of 77%) and PD-L1 negative patients (ORR of 17%; DCR of 58%) Management to host webcast presentation of the interim results today, May 9, 2022 at 2 p.m. CET / 8 a.m. ET OSLO, Norway, May 09, 2022 (GLOBE NEWSWIRE) — Nykode Therapeutics AS (Euronext Growth (Oslo): NYKD), a clinical-stage biopharmaceutical company dedicated to the discovery and development of vaccines and novel immunotherapies, today announced positive interim results from its Phase...

Continue reading

American Premium Mining Corp. (OTC: HIPH) Completes Acquisition of CloudXchange DataCentre Inc. and Begins First Phase of Crypto Mining in Singapore

Written by Customer Service on . Posted in Mergers And Acquisitions.

PLAYA VISTA, CA, May 08, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – American Premium Mining Corporation (OTC:HIPH) (“APM” or the “Company”) is pleased to announce that CloudXchange DataCentre Inc. (“CloudX”), a wholly owned subsidiary that engages in crypto-mining and staking related activities has received delivery and completed the installation of its first phase of crypto mining rigs in Singapore, with all of them now being fully operational. On April 24, 2022, the Company announced its plans to acquire CloudX to focus on crypto-mining related businesses with an earnings guarantee of US$1.5 Million for the first 12 months by the Seller. As part of CloudX risk management strategy, CoudX has diversified its crypto mining rigs operations across multiple currencies, geographies, and service providers. The first...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.